Shanghai Mengchao Cancer Hospital

Shanghai Mengchao Cancer Hospital is a specialized tertiary oncology institution located in Shanghai, China, and is a core component of the Shanghai Cell Therapy Group. Named in honor of Professor Wu Mengchao, the renowned "Father of Chinese Hepatobiliary Surgery," the hospital focuses on integrating advanced cell therapies with traditional cancer treatments. It specializes in precision oncology, offering innovative treatments such as CAR-T cell therapy, immunotherapy, and minimally invasive surgery. As a research-oriented hospital, it serves as a major clinical trial site for novel biopharmaceuticals and cellular products. The facility is equipped with state-of-the-art diagnostic and therapeutic technologies to treat complex malignancies, particularly liver, pancreatic, and gastrointestinal cancers.